Cargando…
Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692100/ https://www.ncbi.nlm.nih.gov/pubmed/36440009 http://dx.doi.org/10.3389/fcvm.2022.1040649 |
_version_ | 1784837186869264384 |
---|---|
author | Capuano, Annalisa Clementi, Emilio Paolisso, Giuseppe |
author_facet | Capuano, Annalisa Clementi, Emilio Paolisso, Giuseppe |
author_sort | Capuano, Annalisa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9692100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96921002022-11-26 Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis Capuano, Annalisa Clementi, Emilio Paolisso, Giuseppe Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2022-11-11 /pmc/articles/PMC9692100/ /pubmed/36440009 http://dx.doi.org/10.3389/fcvm.2022.1040649 Text en Copyright © 2022 Capuano, Clementi and Paolisso. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Capuano, Annalisa Clementi, Emilio Paolisso, Giuseppe Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis |
title | Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis |
title_full | Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis |
title_fullStr | Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis |
title_full_unstemmed | Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis |
title_short | Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis |
title_sort | editorial: clinical prospective of sglt2 inhibitors in atherosclerosis |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692100/ https://www.ncbi.nlm.nih.gov/pubmed/36440009 http://dx.doi.org/10.3389/fcvm.2022.1040649 |
work_keys_str_mv | AT capuanoannalisa editorialclinicalprospectiveofsglt2inhibitorsinatherosclerosis AT clementiemilio editorialclinicalprospectiveofsglt2inhibitorsinatherosclerosis AT paolissogiuseppe editorialclinicalprospectiveofsglt2inhibitorsinatherosclerosis |